Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies

Treatment of myelofibrosis (MF), a BCR-ABL–negative myeloproliferative neoplasm, is challenging. The only current potentially curative option, allogeneic hematopoietic stem cell transplant, is recommended for few patients. The remaining patients are treated with palliative therapies to manage MF-rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Tibes, Raoul, Mesa, Ruben A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975838/
https://www.ncbi.nlm.nih.gov/pubmed/24598114
http://dx.doi.org/10.1186/1756-8722-7-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975838/
https://www.ncbi.nlm.nih.gov/pubmed/24598114
http://dx.doi.org/10.1186/1756-8722-7-18

Ejemplares similares